BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30768150)

  • 1. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.
    Huang L; Brunell D; Stephan C; Mancuso J; Yu X; He B; Thompson TC; Zinner R; Kim J; Davies P; Wong STC
    Bioinformatics; 2019 Oct; 35(19):3709-3717. PubMed ID: 30768150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies.
    Xu J; Regan-Fendt K; Deng S; Carson WE; Payne PRO; Li F
    Pac Symp Biocomput; 2018; 23():92-103. PubMed ID: 29218872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network as a Biomarker: A Novel Network-Based Sparse Bayesian Machine for Pathway-Driven Drug Response Prediction.
    Liu Q; Muglia LJ; Huang LF
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31405013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DrugComboRanker: drug combination discovery based on target network analysis.
    Huang L; Li F; Sheng J; Xia X; Ma J; Zhan M; Wong ST
    Bioinformatics; 2014 Jun; 30(12):i228-36. PubMed ID: 24931988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MODIG: integrating multi-omics and multi-dimensional gene network for cancer driver gene identification based on graph attention network model.
    Zhao W; Gu X; Chen S; Wu J; Zhou Z
    Bioinformatics; 2022 Oct; 38(21):4901-4907. PubMed ID: 36094338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge.
    Ding P; Yin R; Luo J; Kwoh CK
    IEEE J Biomed Health Inform; 2019 May; 23(3):1336-1345. PubMed ID: 29994408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
    Yang H; Wei Q; Zhong X; Yang H; Li B
    Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DGMP: Identifying Cancer Driver Genes by Jointing DGCN and MLP from Multi-omics Genomic Data.
    Zhang SW; Xu JY; Zhang T
    Genomics Proteomics Bioinformatics; 2022 Oct; 20(5):928-938. PubMed ID: 36464123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction.
    Liu X; Song C; Liu S; Li M; Zhou X; Zhang W
    Bioinformatics; 2022 Oct; 38(20):4782-4789. PubMed ID: 36000898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DIGREM: an integrated web-based platform for detecting effective multi-drug combinations.
    Zhang M; Lee S; Yao B; Xiao G; Xu L; Xie Y
    Bioinformatics; 2019 May; 35(10):1792-1794. PubMed ID: 30295728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single and module-based methods for modeling gene regulatory networks.
    Hernaez M; Blatti C; Gevaert O
    Bioinformatics; 2020 Jan; 36(2):558-567. PubMed ID: 31287491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian structural equation modeling in multiple omics data with application to circadian genes.
    Maity AK; Lee SC; Mallick BK; Sarkar TR
    Bioinformatics; 2020 Jul; 36(13):3951-3958. PubMed ID: 32369552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
    Liu Q; Xie L
    PLoS Comput Biol; 2021 Feb; 17(2):e1008653. PubMed ID: 33577560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FORESEE: a tool for the systematic comparison of translational drug response modeling pipelines.
    Turnhoff LK; Hadizadeh Esfahani A; Montazeri M; Kusch N; Schuppert A
    Bioinformatics; 2019 Oct; 35(19):3846-3848. PubMed ID: 30821320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driver gene detection through Bayesian network integration of mutation and expression profiles.
    Chen Z; Lu Y; Cao B; Zhang W; Edwards A; Zhang K
    Bioinformatics; 2022 May; 38(10):2781-2790. PubMed ID: 35561191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feature set optimization in biomarker discovery from genome-scale data.
    Fortino V; Scala G; Greco D
    Bioinformatics; 2020 Jun; 36(11):3393-3400. PubMed ID: 32119073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting synergistic anticancer drug combination based on low-rank global attention mechanism and bilinear predictor.
    Gan Y; Huang X; Guo W; Yan C; Zou G
    Bioinformatics; 2023 Oct; 39(10):. PubMed ID: 37812255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DTF: Deep Tensor Factorization for predicting anticancer drug synergy.
    Sun Z; Huang S; Jiang P; Hu P
    Bioinformatics; 2020 Aug; 36(16):4483-4489. PubMed ID: 32369563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.